Abstract
Objective A “Cluster” is an area with a higher occurrence of tuberculosis than would be expected in an average random distribution of that area. Tuberculosis clustering is commonly reported in Ethiopia, but most studies rely on registered data, which may miss patients who do not visit health facilities or those who attend but are not identified as having tuberculosis. This makes the detection of actual clusters challenging. This study analysed the clustering of pulmonary tuberculosis and associated risk factors using symptom-based population screening in Dale, Ethiopia.
Desgign A prospective population-based cohort study.
Setting All households in 383 enumeration areas were visited three times over 1 year period, at four-month intervals.
Participants Individuals with pulmonary tuberculosis aged ≥15 years with demographic, socioeconomic, clinical, and geographic data residing in 383 enumeration areas (i.e., the lowest unit/village in the kebele, each with approximately 600 residents).
Outcome measures Pulmonary tuberculosis (i.e., bacteriologically confirmed by sputum microscopy, GeneXpert or cluture plus clinically diagnosed pulmonary tuberculosis) and pulmonary tuberculosis clustering.
Results We identified pulmonary tuberculosis clustering in 45 out of the 383 enumeration areas. During the first round of screening, 39 enumeration areas showed pulmonary tuberculosis clustering, compared to only three enumeration areas in the second and third rounds. Our multilevel analysis found that enumeration areas with clusters were located farther from the health centres than other enumeration areas. No other determinants examined were associated with clustering.
Conclusions The distribution of pulmonary tuberculosis was clustered in enumeration areas distant from the health centres. Routine systematic community screening using existing health infrastructure with Health extension workers may be costly but through targeted screening they can identify and refer persons with TB symptoms more quickly for diagnosis and treatment, thereby decreasing the duration of disease transmission and contributing to the reduction of TB burden.
Stregths and limiations of this study
The study applied a three-round total household symptom screening strategy to identify undiagnosed as well as diagnosed tuberculosis cases, and hence identify real clusters.
Health extension workers actively involved the entire population in screening, benefitting from their trust and familiarity with the community.
The study also sought for risk factors for clustering that may require attention from public health practices at the lowest community level.
Smear microscopy will due to relatively low sensitivity always miss some cases of tuberculosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Norwegian Institute of Public Health and the Norwegian Health Association.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was obtained from the Armauer Hansen Reaserch Institute Ethics Review Committee, Ethiopia (PO12/15), National Research Ethics Committee, Ethiopia (no 104/2016), the Regional Committees for Medical and Health Research Ethics in Norway (2015/1006).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
